From effective outbreak control to promising new research, a few developments that suggest key parts of the global health system are still functioning well, even under strain. Get the latest in the ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...

Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically ...